{"id":4827,"date":"2022-01-11T13:30:00","date_gmt":"2022-01-11T13:30:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3626107_AE26107_0"},"modified":"2022-01-11T13:30:00","modified_gmt":"2022-01-11T13:30:00","slug":"cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=4827","title":{"rendered":"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1723116\/Cambrex_40_Years_Logo.jpg?p=medium600 \" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"xn-location\">EAST RUTHERFORD, N.J.<\/span>, <span class=\"xn-chron\">Jan. 11, 2022<\/span> \/PRNewswire\/ &#8212; Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over <span class=\"xn-money\">$100 million<\/span> of investments in progress across its global manufacturing network. <\/p>\n<p>&#8220;As Cambrex celebrates our 40th anniversary, we are proud to be making significant investments in capacity and new capabilities across our network,&#8221; said <span class=\"xn-person\">Thomas Loewald<\/span>, Cambrex CEO. He added, &#8220;Paired with our growing team of over 2,200 employees; these investments will enable us to serve our customers better as we partner with them in the development and manufacturing of novel, life-changing therapies.&#8221;<\/p>\n<p>The largest of the expansions in <span class=\"xn-location\">Charles City, IA<\/span>, is a <span class=\"xn-money\">$50 million<\/span> project to support the large-scale development and manufacturing of small molecule drug substances. As the latest in a series of significant investments at the site, the expansion will increase the facility&#8217;s capacity by approximately 30 percent with reactors sized up to 16,000 liters, ideal for efficient production of large-volume commercial drug substances. The new capacity will come online during the first half of 2022.<\/p>\n<p>In <span class=\"xn-chron\">October 2021<\/span>, a further <span class=\"xn-money\">$30 million<\/span> investment was announced at Cambrex&#8217;s <span class=\"xn-location\">High Point, NC<\/span> facility focused on clinical-stage drug substance and small-volume commercial manufacturing services. Now in progress, the expansion will approximately double the facility&#8217;s capacity by adding new chemistry laboratories, new clinical manufacturing suites, and a small-scale commercial manufacturing operation with reactors up to 2,000 liters. In addition to expanding Cambrex&#8217;s leadership in continuous flow chemistry, this investment will give Cambrex the ability to develop and manufacture highly potent APIs for its customers within a single facility. The <span class=\"xn-location\">High Point<\/span> facility expansion will be completed during the first half of 2023.<\/p>\n<p>In <span class=\"xn-location\">Europe<\/span>, Cambrex is midway through a series of upgrades at its Karlskoga, <span class=\"xn-location\">Sweden<\/span> facility totaling over <span class=\"xn-money\">$20 million<\/span>, which will increase multi-purpose capacity by 25 percent and provide more flexibility in API manufacturing. Less than a year removed from installing a new 6,000-liter drug substance production line, the site is now executing a similar project to add additional cGMP manufacturing capacity by the end of 2022.<\/p>\n<p>These investments, which span all scales of clinical and commercial drug substance manufacturing, will ensure Cambrex continues to be well-positioned to support its customers in the development and manufacturing of innovative new therapies that improve human health.<\/p>\n<p><b>About Cambrex<\/b><\/p>\n<p>Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,200 experts servicing global clients from <span class=\"xn-location\">North America<\/span> and European sites, Cambrex is a trusted partner in branded and generic markets for API and dosage form development and manufacturing.<\/p>\n<p>Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalvsis. continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.<\/p>\n<p>For more information, visit <a target=\"_blank\" href=\"http:\/\/www.cambrex.com\/\" rel=\"nofollow noopener\">www.cambrex.com<\/a> <\/p>\n<p>Contact:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br \/><span class=\"xn-person\">Eli Cohen<\/span>, Sr. Director of Marketing <br \/>Email: <a target=\"_blank\" href=\"mailto:press@cambrex.com\" rel=\"nofollow noopener\">press@cambrex.com<\/a>&nbsp; <br \/>Phone: +1 919 544 8638<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EAST RUTHERFORD, N.J., Jan. 11, 2022 \/PRNewswire\/ &#8212; Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over $100 million of investments in progress [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":4828,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-4827","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=4827\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity - My Blog\" \/>\n<meta property=\"og:description\" content=\"EAST RUTHERFORD, N.J., Jan. 11, 2022 \/PRNewswire\/ &#8212; Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over $100 million of investments in progress [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=4827\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-11T13:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/01\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"266\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity\",\"datePublished\":\"2022-01-11T13:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827\"},\"wordCount\":566,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827\",\"name\":\"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg\",\"datePublished\":\"2022-01-11T13:30:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg\",\"width\":599,\"height\":266},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4827#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=4827","og_locale":"en_US","og_type":"article","og_title":"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity - My Blog","og_description":"EAST RUTHERFORD, N.J., Jan. 11, 2022 \/PRNewswire\/ &#8212; Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over $100 million of investments in progress [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=4827","og_site_name":"My Blog","article_published_time":"2022-01-11T13:30:00+00:00","og_image":[{"width":599,"height":266,"url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/01\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg","type":"image\/jpeg"}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=4827#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4827"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity","datePublished":"2022-01-11T13:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4827"},"wordCount":566,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4827#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/01\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=4827","url":"https:\/\/transmediavictoria.net.au\/?p=4827","name":"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4827#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4827#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/01\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg","datePublished":"2022-01-11T13:30:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4827#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=4827"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=4827#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/01\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/01\/cambrex-celebrates-its-40th-anniversary-while-investing-over-100-million-in-new-drug-substance-manufacturing-capacity.jpg","width":599,"height":266},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=4827#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/4827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4827"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/4827\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/4828"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}